DAVID FARAG: Open Payments
NPI 1609976984 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,727 in 100 payments from 22 companies in 2025. Trend: 2023 $1,749 · 2024 $1,911 · 2025 $1,727
Food & beverage: $1,727
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 13 | $327 |
| PFIZER INC. | 15 | $192 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $155 |
| Regeneron Healthcare Solutions, Inc. | 14 | $140 |
| Journey Medical Corporation | 1 | $122 |
| Amgen Inc. | 1 | $119 |
| LEO Pharma Inc. | 4 | $93 |
| Incyte Corporation | 5 | $88 |
| Botanix SB Inc | 5 | $84 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
Products named: Bimzelx, EMROSI, OTEZLA, CIBINQO, LIBTAYO, ANZUPGO, OPZELURA, SOFDRA.
Industry payments across NJ — which companies pay providers there.
